1.
2.
CNS Spectr
; 26(5): 444-445, 2021 10.
Article
in English
| MEDLINE
| ID: mdl-32594931
Subject(s)
Antipsychotic Agents/therapeutic use , Dopamine Agonists/therapeutic use , Schizophrenia/drug therapy , Substance-Related Disorders/drug therapy , Antipsychotic Agents/administration & dosage , Antipsychotic Agents/adverse effects , Comorbidity , Dopamine Agonists/administration & dosage , Dopamine Agonists/adverse effects , Humans , Receptors, Dopamine D3/agonists , Schizophrenia/complications , Substance-Related Disorders/complications
3.
J Clin Psychiatry
; 81(4)2020 06 16.
Article
in English
| MEDLINE
| ID: mdl-32558406